Granahan Investment Management - XERIS BIOPHARMA HOLDINGS INC ownership

XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 94 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of XERIS BIOPHARMA HOLDINGS INC
ValueSharesWeighting
Q1 2022$1,037,000
-32.5%
405,247
-22.8%
0.03%
-18.8%
Q4 2021$1,537,000524,6120.03%
Other shareholders
XERIS BIOPHARMA HOLDINGS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CAXTON CORP 6,039,028$9,300,00012.49%
Stonepine Capital Management, LLC 11,647,417$17,937,0008.34%
SINECERA CAPITAL, LLC 253,101$390,0000.44%
NEA Management Company, LLC 3,246,785$5,000,0000.26%
ARMISTICE CAPITAL, LLC 5,824,000$8,969,0000.16%
DELTEC ASSET MANAGEMENT LLC 406,000$625,0000.15%
Alpine Global Management, LLC 350,000$539,0000.14%
Redmile Group, LLC 1,046,587$1,612,0000.06%
IHT Wealth Management, LLC 337,387$520,0000.05%
TUDOR INVESTMENT CORP ET AL 960,111$1,479,0000.04%
View complete list of XERIS BIOPHARMA HOLDINGS INC shareholders